Site Finance Command Center
PFE28.41+1.2%
MRK104.22-0.4%
LLY812.05+2.1%
NVS117.88+0.6%
AZN76.30-0.8%
BMY51.14+0.3%
VRTX468.92+1.7%
GILD84.27-0.2%
REGN1,012.55+0.9%
BIIB234.10-1.1%
PFE28.41+1.2%
MRK104.22-0.4%
LLY812.05+2.1%
NVS117.88+0.6%
AZN76.30-0.8%
BMY51.14+0.3%
VRTX468.92+1.7%
GILD84.27-0.2%
REGN1,012.55+0.9%
BIIB234.10-1.1%
Finance / Per-Study Forecast
Study Drill · Crohn's Disease

GI-211 / revenue book

16 active subjects · 72 visits remaining
Recognized YTD
$124.7K
actual
Remaining Contract
$150.5K
under SOW
$ / Subject
$17,200
full course
Q4 Forecast
$275.2K
this quarter
Subject Revenue Waterfall
recognized · remaining
PT-1006PT-1013PT-1004PT-1005PT-1011PT-1012PT-1003PT-1010PT-1002PT-1009PT-1001PT-1008PT-1015PT-1000PT-1007PT-10140450090001350018000
Total contract value · 16 subjects$275,136
Subjects · 16
SubjectVisitsRecog.Status
10003/12$4,299Invoiced
10014/12$5,732Invoiced
10025/12$7,165Invoiced
10036/12$8,598Pending
10047/12$10,031Invoiced
10057/12$10,031Hold
10068/12$11,464Invoiced
10073/12$4,299Invoiced
10084/12$5,732Invoiced
10095/12$7,165Invoiced
10106/12$8,598Pending
10117/12$10,031Invoiced
10127/12$10,031Hold
10138/12$11,464Invoiced
10143/12$4,299Invoiced
10154/12$5,732Invoiced
Visit Schedule · next 12 weeks · billable revenue
W1W2W3W4W5W6W7W8W9W10W11W120350070001050014000
AR Aging · this study
0-30 days$22,440
5 invoices
31-60 days$11,220
3 invoices
61-90 days$4,986
1 invoices
90+ days$2,493
1 invoices

Made with Emergent